{"id":"https://openalex.org/A5000709034","orcid":"https://orcid.org/0000-0001-6118-0509","observed_orcids":["https://orcid.org/0000-0001-6118-0509"],"display_name":"Ian Hutchinson","raw_author_names":["Ian Hutchinson"],"full_name":"Ian Hutchinson","works_count":15,"cited_by_count":84,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":2,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5000709034","orcid":"https://orcid.org/0000-0001-6118-0509","observed_orcids":["https://orcid.org/0000-0001-6118-0509"]},"affiliations":[{"institution":{"id":"https://openalex.org/I105036370","ror":"https://ror.org/04r9x1a08","display_name":"AstraZeneca (United Kingdom)","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},"years":[2022]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","count":15,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":11,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","count":9,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","count":4,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","value":0.0001513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13105","display_name":"Synthesis and pharmacology of benzodiazepine derivatives","value":0.0001156,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12477","display_name":"Toxin Mechanisms and Immunotoxins","value":5.19e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","value":4.35e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":2.47e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.7306259870529175},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.6113287210464478},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.569668173789978},{"id":"159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","score":0.5678109526634216},{"id":"542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","score":0.37854501605033875}],"counts_by_year":[{"year":2022,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2023,"works_count":9,"oa_works_count":9,"cited_by_count":14},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2025,"works_count":4,"oa_works_count":4,"cited_by_count":25},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":24}],"display_name_alternatives":["Ian Hutchinson"],"block_key":"i hutchinson","works_api_url":"https://api.openalex.org/works?filter=author.id:A5000709034","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5000709034","updated_date":"2026-11-12T13:17:38","created_date":"2022-07-09T00:00:00"}